Streetbeat News

Revenues

BEN

Franklin Resources (NYSE:BEN) received mixed analyst ratings in the latest quarter, with a shift towards more bearish perspectives. The average 12-month price target was adjusted to $26.19, down from $27.31, reflecting a 4.1% decline. Analysts from Evercore ISI Group, BMO Capital, Morgan Stanley, and Goldman Sachs adjusted their ratings and price targets, indicating varying expectations for BEN's performance. Franklin Resources, with $1.335 trillion in managed assets, shows below-average market capitalization and revenue growth compared to industry peers, alongside challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 3:00 pm

CRTO

Six analysts have recently updated their ratings on Criteo (NASDAQ:CRTO), showing a mix of bullish and neutral stances, with an average 12-month price target of $35.17, indicating a 29.3% increase from the previous target. The updates reflect changes in market conditions and Criteo's performance, with recent financials showing positive revenue growth, high net margin, and strong ROE and ROA, but below-average market capitalization and debt management.

Portfolio Pulse from Benzinga Insights

April 30, 2024 | 3:00 pm

HPCO

Hempacco and Illumination Brands have entered into a non-binding LOI to merge their US operations, retaining the name 'Illumination Brands' and Hempacco's Nasdaq listing. The merger is expected to generate approximately $35M in annual revenues for the combined entity, according to an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 2:55 pm

THC

Tenet Healthcare Corporation (NYSE:THC) reported first-quarter sales of $5.37 billion, a 7% increase year over year, surpassing the consensus of $5.15 billion. Adjusted EBITDA for Q1 2024 was $1.024 billion, up from $832 million the previous year, driven by strong admission growth, favorable payer mix, and improved contract labor costs. The company raised its fiscal year 2024 revenue guidance to $20 billion-$20.4 billion and adjusted EPS guidance to $8.37-$9.41, significantly above the consensus of $6.11. Shares of THC surged 9.97% to $109.08.

Portfolio Pulse from Vandana Singh

April 30, 2024 | 2:53 pm

LLY

Eli Lilly expects acceleration and revenue growth through H2 2024 due to increased supply of incretin medicines. The company is investing to expand capacity for these medicines. Additionally, Eli Lilly anticipates CMS and Medicare coverage for Zepbound, its obstructive sleep apnea treatment, at launch.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 2:47 pm

LLY

Eli Lilly is intensifying efforts to increase the supply of Tirzepatide, expecting significant shipment volume growth in H2 2024. The company confirms it is on track to meet its previously set production goals for incretin medicines, projecting at least a 1.5x increase in salable doses of incretin medicine in H2 2024 compared to H2 2023.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 2:46 pm

LLY

Eli Lilly is advancing its plans to boost manufacturing capacity, including FDA approval for a Wisconsin facility acquired from Nexus Pharma. The company aims to start production by the end of 2025, as demand for Tirzepatide still exceeds supply despite increased production.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 2:46 pm

SPY

The Dallas Fed reported that services revenues for April were at 0.3, a significant decrease from the previous 4.0.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 2:30 pm

MUSQ

SIRI

UFO

Sirius XM Holdings Inc (NASDAQ: SIRI) reported a slight revenue growth in Q1 2024, with a 1% increase year-on-year to $2.16 billion, surpassing consensus estimates. Despite a dip in subscriber numbers, advertising revenue saw significant growth. The company's adjusted EPS met expectations, and it reiterated its FY24 outlook, maintaining revenue and adjusted EBITDA forecasts. Sirius XM's stock has seen a decline over the past year, with a notable 5.3% drop recently. The company is also featured in the Procure Space ETF (NASDAQ: UFO) and Exchange Traded Concepts Trust MUSQ Global Music Industry ETF (NYSE: MUSQ).

Portfolio Pulse from Anusuya Lahiri

April 30, 2024 | 2:30 pm

EAT

Brinker International Inc (NYSE:EAT), the parent company of Chili's, saw its shares increase after reporting a 3.4% year-on-year revenue growth to $1.120 billion for Q3 FY24, in line with estimates. Comparable restaurant sales rose, with Chili's at 3.5% and Maggiano's at 1.7%. Operating margin expanded to 6.2%, and operating income rose 8.8% to $69.9 million. Adjusted EBITDA and EPS also saw increases, with EPS beating consensus. Brinker raised its FY24 EPS and revenue outlook, leading to a 6.78% stock price increase.

Portfolio Pulse from Shivani Kumaresan

April 30, 2024 | 2:29 pm